There are 115 papers on MMP1 in aging research: 3 trials and 32 observational studies in people, 26 in animals, 48 in cells, 6 reviews.
1 new paper in 30 daysSee all 115 papers on MMP1
At a glance
The findings reach people, from one lab or study. 21 independent labs in 11 countries; 13 trials, 4 with no results posted.
“matrix metalloproteinase 1 (MMP1) quartiles 2-4 had lower odds of MCI compared to quartile 1 (Q2: OR = 0.61, 95% CI: 0.35-1.02; Q3: OR = 0.58, 95% CI: 0.33-0.98; Q4: OR = 0.64, 95% CI: 0.37-1.08).”
None of its findings points the other way.
- 21 independent labs in 11 countries
- 13 trials, 4 with no results posted
- Funders: National Institutes of Health and others
- 1 of 28 findings with company ties
- 2 of 13 trials sponsored by developers of drugs aimed at it
- Human trial3
- Humans32
- Animals22
- Model organisms4
- Cells48
Interventions
10Dehydroepiandrosterone
downin human cells1downin humans1
1 study
Dehydroepiandrosterone
downin human cells1downin humans1
Dehydroepiandrosterone decreases MMP1 in ethanol:olive oil (1:2).
“topical DHEA significantly decreased the basal expression of MMP-1 mRNA and protein”
Human trialin ethanol:olive oil (1:2)topicalbuttock skin5%4 weeks
Modulation of collagen metabolism by the topical application of dehydroepiandrosterone to human skin
The Journal of investigative dermatology
Dehydroepiandrosterone inhibits MMP1 in cultured dermal fibroblasts.
“DHEA was found to inhibit ultraviolet (UV)-induced MMP-1 production”
Cellsin cultured dermal fibroblastsdermal fibroblasts
Modulation of collagen metabolism by the topical application of dehydroepiandrosterone to human skin
The Journal of investigative dermatology
Atelocollagen
downin mice1
1 study
Atelocollagen
downin mice1
Atelocollagen decreases MMP1 in mice (aged skin).
“while MMP1, MMP2, and MMP9 were reduced.”
Animalsaged skinskin6% formulation
Journal of functional biomaterials
Sodium butyrate
upin human cells1
1 study
Sodium butyrate
upin human cells1
Sodium butyrate increases MMP1 in CSS-treated cells.
“Histone deacetylase inhibitors, sodium acetate, propionate, and butyrate, all enhanced the CSS-induced MMP-1 according to the degree of histone acetylation.”
Cellsin CSS-treated cells
Genes and environment : the official journal of the Japanese Environmental Mutagen Society
UVA + cigarette sidestream smoke
upin human cells1
1 study
UVA + cigarette sidestream smoke
upin human cells1
UVA + cigarette sidestream smoke increases MMP1 in human cells (coexposure to UVA and CSS).
“Combined exposure to UVA and CSS enhanced MMP-1 induction, accompanied by collagen type I (COL1A1) gene suppression.”
Cellscoexposure to UVA and CSS
Genes and environment : the official journal of the Japanese Environmental Mutagen Society
Urolithin A
downin human cells1
1 study
Urolithin A
downin human cells1
Urolithin A decreases MMP1 in HT29, SW480 and SW620 cells at 100 μM (more than 43% (HT29), 28% (SW480), 90% (SW620) versus control).
“UA inhibits cellular metastasis by lowering the expression levels of matrix metalloproteinases 1 and 2 (MMP1 and MMP2) by more than 43% and 41% (p < .001) in HT29”
Cellsin HT29, SW480 and SW620 cells at 100 μM100 μM
Cell biochemistry and function
Hesperetin
downin human cells1
1 study
Hesperetin
downin human cells1
Hesperetin decreases MMP1 in human cells (UVB-induced damage in keratinocytes).
“hesperetin alleviates UVB-induced damage and suppresses matrix metalloproteinase-1 expression”
CellsUVB-induced damage in keratinocyteskeratinocyte
Journal of biomedical science
Elamipretide
downin human cells1
1 study
Elamipretide
downin human cells1
Elamipretide decreases MMP1 in degenerative tenocytes.
“matrix metalloproteinase-1 (matrix remodeling, P = .029) and fatty acid-binding protein 4 (fatty infiltration, P = .046) was significantly upregulated in the degenerative tenocytes and reduced by SS-31 treatment”
Cellsin degenerative tenocytes1μM72 hours
Evaluation of SS-31 as a Potential Strategy for Tendinopathy Treatment: An In Vitro Model
The American journal of sports medicine
Normoxia
upin human cells1
1 study
Normoxia
upin human cells1
Normoxia increases MMP1 in human cells (compared with 5% O2; COL1A1 was downregulated).
“Upregulation of MMP1 and downregulation of COL1A1”
Cellscompared with 5% O2; COL1A1 was downregulated21% O2dermal fibroblastserial passaging
Oxidative medicine and cellular longevity
Collagen peptides
downin human cells1
1 study
Collagen peptides
downin human cells1
Collagen peptides inhibit MMP1 in human dermal fibroblasts.
“decreased collagen I metabolism through inhibition of metalloproteinase activity (MMP) 1 and 2”
Cellsin human dermal fibroblasts
Cell biology international
Pten gene transfer
downin human cells1
1 study
Pten gene transfer
downin human cells1
Pten gene transfer inhibits MMP1 in human cells (replicative senescence).
“inhibition of the PI3K signalling pathway by PTEN gene transfer abolished the NOX-4 and MMP-1 expression.”
Cellsreplicative senescencedermis
Journal of cellular and molecular medicine
Effects
7PI3K–AKT signaling
upin human cells1
1 study
PI3K–AKT signaling
upin human cells1
MMP1 activates PI3K–AKT signaling in human cells.
“MMP1 acted by activating the PI3K-AKT-mTOR pathway.”
Cells
Oncogene
Tumor-promoting effects of exosomes
upin human cells1
1 study
Tumor-promoting effects of exosomes
upin human cells1
MMP1 increases tumor-promoting effects of exosomes in human cells (shown by knockdown).
“Knocking down MMP1 or using PAR1 inhibitors reduced the tumor-promoting effects of DHLF-derived exosomes in vivo and in vitro.”
Cellsshown by knockdown
Oncogene
Dermal collagen surface roughness
upin humans1
1 study
Dermal collagen surface roughness
upin humans1
MMP1 is linked with higher dermal collagen surface roughness in humans (age-related elevation).
“the age-related elevation of matrix metalloproteinase-1 (MMP-1) and advanced glycation end products (AGEs) are responsible for rougher and stiffer/harder dermal collagen, respectively.”
Humansage-related elevationdermis
Age-related changes in dermal collagen physical properties in human skin
PloS one
Inflammation
upin mice1
1 study
Inflammation
upin mice1
MMP1 induces inflammation in Col1a2; hMMP1 mice.
“reduced collagen production, increased expression of multiple endogenous MMPs, and proinflammatory mediators.”
Animalsin Col1a2; hMMP1 miceskin dermis
The Journal of investigative dermatology
Dermal collagen fibrils
downin mice1
1 study
Dermal collagen fibrils
downin mice1
MMP1 decreases dermal collagen fibrils in Col1a2; hMMP1 mice.
“At 6 months of age, Col1a2;hMMP1 mice displayed loss and fragmentation of dermal collagen fibrils”
Animalsin Col1a2; hMMP1 miceskin dermis
The Journal of investigative dermatology
Neurotransmitter release
downin flies1
1 study
Neurotransmitter release
downin flies1
MMP1 decreases neurotransmitter release in flies (temporally controlled overexpression in motor neurons).
“overexpression of dMMP1 specifically in motor neurons was sufficient to induce deficits in climbing behavior and cause a decrease in neurotransmitter release at neuromuscular synapses.”
Model organismstemporally controlled overexpression in motor neuronsneuromuscular junction
Aging cell
Climbing behavior
downin flies1
1 study
Climbing behavior
downin flies1
MMP1 impairs climbing behavior in flies (temporally controlled overexpression).
“Temporally controlled overexpression of dMMP1 specifically in motor neurons was sufficient to induce deficits in climbing behavior”
Model organismstemporally controlled overexpressionmotor neuron
Aging cell
Upstream
4ATXN1
upin flies1
1 study
ATXN1
upin flies1
ATXN1 increases MMP1 in flies (pan-neuronal expression of human Ataxin-1 (82Q)).
“coupled to an enhancement of matrix metalloproteinase 1 (dMMP1) expression”
Model organismspan-neuronal expression of human Ataxin-1 (82Q)males
Biology
Aged vocal fold fibroblasts
downin rat cells1
1 study
Aged vocal fold fibroblasts
downin rat cells1
aged vocal fold fibroblasts decrease MMP1 in rat cells.
“accompanied with decreased Mmp1 and unchanged Col1a1 transcription”
Cellsvocal fold
Characterization of aged rat vocal fold fibroblasts
The Laryngoscope
cellular replicative senescence
upin human cells1
1 study
cellular replicative senescence
upin human cells1
cellular replicative senescence induces MMP1 in human cells (replicative senescence versus young cells (22PDL)) (5.1-fold).
“The expression of MMP1 was up-regulated 5.1-fold obviously (P<0.05).”
Cellsreplicative senescence versus young cells (22PDL)lung fibroblast
Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases
CDKN2A
upin human cells1
1 study
CDKN2A
upin human cells1
CDKN2A induces MMP1 in human cells (when overexpressed in chondrocytes).
“When overexpressed in chondrocytes, p16INK4a is sufficient to induce the production of the two matrix remodeling enzymes, MMP1 and MMP13”
Cellswhen overexpressed in chondrocytes
Arthritis research & therapy
Associations
7Non-AIDS-defining cancer
upin humans1
1 study
Non-AIDS-defining cancer
upin humans1
MMP1 is linked with a higher risk of non-AIDS-defining cancer in people with HIV on antiretroviral therapy (aHR=2.32).
“The strongest associations were found for PD-L2 (aHR=3.33), PAI-1 (aHR=2.27), and MMP-1 (aHR=2.32).”
Humansin people with HIV on antiretroviral therapyplasma
Frontiers in immunology
Cortical thickness
downin silico1
1 study
Cortical thickness
downin silico1
MMP1 is associated with cortical thickness in silico (β = -2.49, p = 0.0091).
“higher MMP-1 concentrations associated with accelerated cortical thinning (β = -2.49, p = 0.0091)”
In silico
Brain imaging and behavior
Endometriosis
upin humans1
1 study
Endometriosis
upin humans1
Endometriosis is associated with MMP1 in endometriotic lesions compared with eutopic endometrium.
“MMP-1 and MMP-3 protein levels were elevated in endometriotic lesions compared with those in the eutopic endometrium”
Humansin endometriotic lesions compared with eutopic endometriumendometriotic lesionsfemales
Einstein (Sao Paulo, Brazil)
Mild cognitive impairment
downin humans1OR 0.58
1 study
Mild cognitive impairment
downin humans1OR 0.58
MMP1 is linked with a lower risk of mild cognitive impairment in humans (at high risk of mobility disability) (Q3 vs Q1: OR 0.58 (95% CI: 0.33-0.98)).
“matrix metalloproteinase 1 (MMP1) quartiles 2-4 had lower odds of MCI compared to quartile 1 (Q2: OR = 0.61, 95% CI: 0.35-1.02; Q3: OR = 0.58, 95% CI: 0.33-0.98; Q4: OR = 0.64, 95% CI: 0.37-1.08).”
Humansat high risk of mobility disabilityn = 1,373
The journal of nutrition, health & aging
Bone mineral density
downin humans1
1 study
Bone mineral density
downin humans1
MMP1 is associated with bone mineral density in humans (rs5854).
“rs5854 (MMP1) and rs2910164 (miR-146a) were associated with low bone mineral density”
Humansrs5854
MicroRNA binding site variants-new potential markers of primary osteoporosis in men and women
Frontiers in genetics
Cardio-metabolic disorders
mixedin humans1
1 study
Cardio-metabolic disorders
mixedin humans1
MMP1 is associated with cardio-metabolic disorders in humans (elderly individuals with CMDs).
“MMP1 was the most differentially expressed hub protein in CMDs”
Humanselderly individuals with CMDs
Clinical proteomics
Skin papilloma
upin mice1
1 study
Skin papilloma
upin mice1
MMP1 raises the risk of skin papilloma in Col1a2; hMMP1 mice.
“Col1a2;hMMP1 mice displayed substantially increased susceptibility to skin papilloma development.”
Animalsin Col1a2; hMMP1 miceskin dermis
The Journal of investigative dermatology